Advertisement

Topics

Schrödinger, Inc. Company Profile

03:20 EST 17th December 2018 | BioPortfolio

Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry; it has achieved breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, scoring, and virtual screening. The company’s full product offerings range from general molecular modeling programs to a comprehensive suite of drug design software. Besides the company’s industry-leading drug discovery solutions, Schrödinger is actively developing state-of-the art simulation tools for materials research as well as enterprise software that can be deployed throughout an entire research organization. Schrödinger’s methods development and applications papers have thousands of citations and are often among the most-cited scientific publications. Schrödinger’s science is continually validated internally and by its users worldwide. Founded in 1990, Schrödinger has operations in the United States as well as in Europe, India, and Japan. For more information, please visit www.schrodinger.com.


News Articles [29 Associated News Articles listed on BioPortfolio]

Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery

The joint team is focused on the discovery of efficacious inhibitors of PknB, which is essential for the growth of Mycobacterium tuberculosis (TB). Schrödinger’s computational platform has led The...

Schrödinger and WuXi AppTec Launch Faxian Therapeutics to Enable Accelerated Drug Discovery

NewsThe agreement will leverage the precision molecular design platforms developed by Schrödinger and accelerate them through partnership with the optimization services provided by WuXi AppTec.

Schrödinger and WuXi AppTec Announce the Launch of Faxian Therapeutics to Enable Accelerated ...

NEW YORK and SHANGHAI, Oct. 30, 2018 /PRNewswire/ -- Schrödinger, a privately-held company revolutionizing drug discovery through advanced computational methods and enterprise software solutions, and...

WuXi AppTec and Schrödinger Form Faxian for Novel Drug Discovery

WuXi AppTec will form Faxian Therapeutics with Schrödinger, a New York City company that offers drug discovery using advanced computational methods. WuXi will add its lead optimization CRO servic...

Partnership will expand research into ‘urgently needed’ area

SPARC and SchrÃdinger will collaborate to use SchrÃdingerâs technological platforms and SPARCâs insights into research therapeutics for neurodegenerative conditions.

Peter Jonas receives Erwin Schrödinger Prize of the Austrian Academy of Sciences

(Institute of Science and Technology Austria) Peter Jonas, Professor at the Institute of Science and Technology Austria (IST Austria), receives the Erwin Schrödinger Prize of the Austrian Academy of ...

WuXi AppTec, Schrödinger launch ‘virtual global collaboration’ as part of drug discovery tie-up

The CDMO WuXi AppTec and SchrÃdinger have launched Faxian Therapeutics, a new company that will focus on accelerating drug discovery and advancing new therapies through global collaboration.

Schrödinger’s cat among biology’s pigeons: 75 years of What Is Life?

Drugs and Medications [0 Results]

None

PubMed Articles [46 Associated PubMed Articles listed on BioPortfolio]

Bound state solutions of Schrödinger equation with modified Mobius square potential (MMSP) and its thermodynamic properties.

We solved the Schrödinger equation with the modified Mobius square potential model using the modified factorization method. Within the framework of the Greene-Aldrich approximation for the centrifuga...

Pyridyl thiosemicarbazide: synthesis, crystal structure, DFT/B3LYP, molecular docking studies and its biological investigations.

N-(pyridin-2-yl)hydrazinecarbothioamide has been synthesized and characterized by single-crystal X-ray and spectroscopic techniques. Furthermore, its geometry optimization, calculated vibrational freq...

Exponential propagators for the Schrödinger equation with a time-dependent potential.

We consider the numerical integration of the Schrödinger equation with a time-dependent Hamiltonian given as the sum of the kinetic energy and a time-dependent potential. Commutator-free (CF) propaga...

Implicit finite-difference schemes, based on the Rosenbrock method, for nonlinear Schrödinger equation with artificial boundary conditions.

We investigate the effectiveness of using the Rosenbrock method for numerical solution of 1D nonlinear Schrödinger equation (or the set of equations) with artificial boundary conditions (ABCs). We co...

The challenge of synthetic biology. Synthetic Darwinism and the aperiodic crystal structure.

'Grand Challenges' offer ways to discover flaws in existing theory without first needing to guess what those flaws are. Our grand challenge here is to reproduce the Darwinism of terran biology, but on...

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Schrödinger

Schrödinger is widely recognized as a scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical and biotechnology research. The company's products range ...

Schrödinger Inc.

Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry; it has achieved breakthroughs in quantum chemistry, m...

Schrödinger, Inc.

Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry; it has achieved breakthroughs in quantum chemistry, m...

Nimbus Discovery LLC

Nimbus Discovery is applying advances in computer-based drug discovery to develop new medicines against important drug targets and thereby unlock fundamental biological pathways. ...

Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on integrin biology breakthroughs from the lab of noted entrepreneur...

More Information about "Schrödinger, Inc." on BioPortfolio

We have published hundreds of Schrödinger, Inc. news stories on BioPortfolio along with dozens of Schrödinger, Inc. Clinical Trials and PubMed Articles about Schrödinger, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schrödinger, Inc. Companies in our database. You can also find out about relevant Schrödinger, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record